For those watching the generics marketplace over the past few years, the industry has been anything but boring or conventional.
Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief
Advertisement
Troy Trygstad, PharmD, PhD, MBA, is the executive director of CPESN USA, a clinically integrated network of more than 3500 participating pharmacies. He received his PharmD and MBA degrees from Drake University and a PhD in pharmaceutical outcomes and policy from the University of North Carolina. He has recently served on the board of directors for the Pharmacy Quality Alliance and the American Pharmacists Association Foundation. He also proudly practiced in community pharmacies across the state of North Carolina for 17 years.
Articles by Troy Trygstad, PharmD, PhD, MBA, Pharmacy Times Editor in Chief
For more than 3 decades now, pharmacy has been talking the talk but has struggled to walk the walk.
We can do more than act as dispensing police and check in with our state Prescription Drug Monitoring System; we can play an active role in preventing and treating this disease called drug addiction.
The magnitude of the benefit of OTC medications to the health care system is often underappreciated.
The term bellwether comes from an ageold practice in sheepherding of putting a bell on the sheep that leads the flock.
Groupthink can lead to decisions and actions within, and by, a group that are curious, seemingly disconnected, and often misunderstood from the perspective of stakeholders outside the group.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
2
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
3
First FDA-Approved Oral Liquid Sitagliptin for Adults with Type 2 Diabetes
4
Oxaliplatin as Part of Sequential Chemotherapy Shows Promise in Metastatic Pancreatic Cancer
5
